R. 1. Sgonc, R. Gruschwitz, M. Dietrich, H. Recheis, H. Gershwin et al., Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma., Journal of Clinical Investigation, vol.98, issue.3, pp.785-92, 1996.
DOI : 10.1172/JCI118851

P. Rossi, B. Granel, D. Marziale, L. Mée, F. Francès et al., Endothelial function and hemodynamics in systemic sclerosis, Clinical Physiology and Functional Imaging, vol.11, issue.6, pp.453-462, 2010.
DOI : 10.1111/j.1475-097X.2010.00965.x

A. Blann, A. Woywodt, F. Bertolini, T. Bull, J. Buyon et al., Circulating endothelial cells. Biomarker of vascular disease, Thrombosis and Haemostasis, vol.93, pp.228-263, 2005.
DOI : 10.1160/TH04-09-0578

G. Chironi, C. Boulanger, A. Simon, F. Dignat-george, J. Freyssinet et al., Endothelial microparticles in diseases, Cell and Tissue Research, vol.13, issue.1868, pp.143-51, 2009.
DOI : 10.1161/hc4301.098284

J. Quilici, N. Banzet, P. Paule, J. Meynard, M. Mutin et al., Circulating Endothelial Cell Count as a Diagnostic Marker for Non-ST-Elevation Acute Coronary Syndromes, Circulation, vol.110, issue.12, pp.1586-91, 2004.
DOI : 10.1161/01.CIR.0000142295.85740.98

M. Mutin, I. Canavy, A. Blann, M. Bory, J. Sampol et al., Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells, Blood, vol.93, pp.2951-2959, 1999.

A. Widemann, C. Pasero, L. Arnaud, P. Poullin, A. Loundou et al., Circulating endothelial cells and progenitors as prognostic factors during autoimmune thrombotic thrombocytopenic purpura: results of a prospective multicenter French study, Journal of Thrombosis and Haemostasis, vol.73, issue.Suppl. 1, pp.1601-1610, 2014.
DOI : 10.1128/IAI.73.12.8306-8316.2005

B. Parker, A. Husain, P. Pemberton, A. Yates, P. Ho et al., Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus, Annals of the Rheumatic Diseases, vol.4, issue.6, pp.1144-50, 2014.
DOI : 10.2147/VHRM.S955

S. Guiducci, J. Distler, A. Jüngel, D. Huscher, L. Huber et al., The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis, Arthritis & Rheumatism, vol.2, issue.9, pp.2845-53, 2008.
DOI : 10.1161/01.CIR.101.8.841

T. Asahara, T. Murohara, A. Sullivan, M. Silver, R. Van-der-zee et al., Isolation of Putative Progenitor Endothelial Cells for Angiogenesis, Science, vol.149, issue.5302, pp.964-971, 1997.
DOI : 10.1016/0006-291X(91)91276-I

V. Zaccone, F. R. Santoro, L. , D. Matteis, G. Giupponi et al., Focus on biological identity of endothelial progenitors cells, Eur Rev Med Pharmacol Sci, vol.19, pp.4047-63, 2015.

A. Attar, K. Aghasadeghi, M. Parsanezhad, N. Jahromi, B. Habibagahi et al., Absence of Correlation between Changes in the Number of Endothelial Progenitor Cell Subsets, Korean Circulation Journal, vol.45, issue.4, pp.325-357, 2015.
DOI : 10.4070/kcj.2015.45.4.325

M. Kuwana, Y. Okazaki, H. Yasuoka, Y. Kawakami, and Y. Ikeda, Defective vasculogenesis in systemic sclerosis, The Lancet, vol.364, issue.9434, pp.603-613, 2004.
DOI : 10.1016/S0140-6736(04)16853-0

D. Papa, N. Colombo, G. Fracchiolla, N. Moronetti, L. Ingegnoli et al., Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis, Arthritis & Rheumatism, vol.30, issue.4, pp.1296-304, 2004.
DOI : 10.1002/art.1780341204

Y. Allanore, F. Batteux, J. Avouac, N. Assous, B. Weill et al., Levels of circulating endothelial progenitor cells in systemic sclerosis, Clin Exp Rheumatol, vol.25, pp.60-66, 2007.

J. Avouac, F. Juin, J. Wipff, P. Couraud, G. Chiocchia et al., Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity, Annals of the Rheumatic Diseases, vol.67, issue.10, pp.1455-60, 2008.
DOI : 10.1136/ard.2007.082131

D. Papa, N. Quirici, N. Soligo, D. Scavullo, C. Cortiana et al., Bone marrow endothelial progenitors are defective in systemic sclerosis, Arthritis & Rheumatism, vol.28, issue.8, pp.2605-2620, 2006.
DOI : 10.1002/art.1780341204

M. Mok, K. Yiu, C. Wong, J. Qiuwaxi, W. Lai et al., Low circulating level of CD133 + KDR + cells in patients with systemic sclerosis

T. Nevskaya, S. Bykovskaia, E. Lyssuk, I. Shakhov, M. Zaprjagaeva et al., Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations, Clin Exp Rheumatol, vol.26, pp.421-430, 2008.

S. Zhu, S. Evans, B. Yan, T. Povsic, V. Tapson et al., Transcriptional Regulation of Bim by FOXO3a and Akt Mediates Scleroderma Serum???Induced Apoptosis in Endothelial Progenitor Cells, Circulation, vol.118, issue.21, pp.2156-65, 2008.
DOI : 10.1161/CIRCULATIONAHA.108.787200

J. Avouac, C. Meune, B. Ruiz, P. Couraud, G. Uzan et al., Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis, Annals of the Rheumatic Diseases, vol.71, issue.3, pp.394-403, 2012.
DOI : 10.1136/annrheumdis-2011-200143

J. Distler, Y. Allanore, J. Avouac, R. Giacomelli, S. Guiducci et al., EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells, Annals of the Rheumatic Diseases, vol.68, issue.2, pp.163-171, 2009.
DOI : 10.1136/ard.2008.091918
URL : http://www.zora.uzh.ch/id/eprint/27419/1/Distler_JH_et_al%2C_EP_cell_Ann_Rheum_Dis_2009.pdf

A. Brunasso and C. Massone, Update on the pathogenesis of Scleroderma: focus on circulating progenitor cells, F1000Research, vol.5, 2016.
DOI : 10.12688/f1000research.7986.1

J. Case, L. Mead, W. Bessler, D. Prater, H. White et al., Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors, Experimental Hematology, vol.35, issue.7, pp.1109-1127, 2007.
DOI : 10.1016/j.exphem.2007.04.002

J. Hill, G. Zalos, J. Halcox, W. Schenke, M. Waclawiw et al., Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk, New England Journal of Medicine, vol.348, issue.7, pp.593-600, 2003.
DOI : 10.1056/NEJMoa022287

G. Padfield, O. Tura, M. Haeck, A. Short, E. Freyer et al., Circulating endothelial progenitor cells are not affected by acute systemic inflammation, American Journal of Physiology-Heart and Circulatory Physiology, vol.22, issue.6, pp.2054-61, 2010.
DOI : 10.1152/ajpheart.00665.2008

G. Padfield, O. Tura-ceide, E. Freyer, G. Barclay, M. Turner et al., Endothelial progenitor cells, atheroma burden and clinical outcome in patients with coronary artery disease, Heart, vol.83, issue.4, pp.791-799, 2013.
DOI : 10.1093/cvr/cvp123

G. Padfield, O. Tura-ceide, E. Freyer, G. Barclay, M. Turner et al., cells, Open Heart, vol.89, issue.1, p.47, 2014.
DOI : 10.1136/hrt.2008.146662
URL : https://hal.archives-ouvertes.fr/hal-00552481

M. Kahaleh, Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action, Arthritis & Rheumatism, vol.159, issue.8, pp.978-83, 1991.
DOI : 10.1111/j.1349-7006.1989.tb02310.x

M. Hasegawa, S. Sato, T. Echigo, Y. Hamaguchi, M. Yasui et al., Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis, Annals of the Rheumatic Diseases, vol.64, issue.1, pp.21-29, 2005.
DOI : 10.1136/ard.2003.018705

R. Channick, G. Simonneau, O. Sitbon, I. Robbins, A. Frost et al., Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study, The Lancet, vol.358, issue.9288, pp.1119-1142, 2001.
DOI : 10.1016/S0140-6736(01)06250-X

J. Korn, M. Mayes, M. Cerinic, M. Rainisio, M. Pope et al., Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist, Arthritis & Rheumatism, vol.132, issue.12, pp.3985-93, 2004.
DOI : 10.7326/0003-4819-132-6-200003210-00002

J. Bazan, K. Bacon, G. Hardiman, W. Wang, K. Soo et al., A new class of membrane-bound chemokine with a CX3C motif, Nature, vol.385, issue.6617, pp.640-644, 1997.
DOI : 10.1038/385640a0

H. Umehara, E. Bloom, T. Okazaki, Y. Nagano, Y. O. Imai et al., Fractalkine in Vascular Biology: From Basic Research to Clinical Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.1, pp.34-40, 2004.
DOI : 10.1161/01.ATV.0000095360.62479.1F

M. Nishimura, H. Umehara, T. Nakayama, O. Yoneda, K. Hieshima et al., Dual Functions of Fractalkine/CX3C Ligand 1 in Trafficking of Perforin+/Granzyme B+ Cytotoxic Effector Lymphocytes That Are Defined by CX3CR1 Expression, The Journal of Immunology, vol.168, issue.12, pp.6173-80, 2002.
DOI : 10.4049/jimmunol.168.12.6173

B. Marasini, R. Cossutta, C. Selmi, M. Pozzi, M. Gardinali et al., Polymorphism of the Fractalkine Receptor CX3CR1 and Systemic Sclerosis-associated Pulmonary Arterial Hypertension, Clinical and Developmental Immunology, vol.200, issue.4, pp.275-284, 2005.
DOI : 10.1080/17402520500303297

M. Arai, Y. Ikawa, S. Chujo, Y. Hamaguchi, W. Ishida et al., Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in the mouse model of cytokine-induced systemic sclerosis, Journal of Dermatological Science, vol.69, issue.3, pp.250-258, 2013.
DOI : 10.1016/j.jdermsci.2012.10.010

F. Van-den-hoogen, D. Khanna, J. Fransen, S. Johnson, M. Baron et al., 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative, Annals of the Rheumatic Diseases, vol.62, issue.(Suppl), pp.2737-2784, 2013.
DOI : 10.1002/art.27580

M. Jr, T. Silman, A. Steen, V. Black, C. Akesson et al., A disease severity scale for systemic sclerosis: development and testing

R. Lacroix, C. Judicone, M. Mooberry, M. Boucekine, N. Key et al., Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop, Journal of Thrombosis and Haemostasis, vol.10, issue.6, pp.1190-1193, 2013.
DOI : 10.1111/jth.12012

S. Robert, R. Lacroix, P. Poncelet, K. Harhouri, T. Bouriche et al., High-Sensitivity Flow Cytometry Provides Access to Standardized Measurement of Small-Size Microparticles--Brief Report, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.32, issue.4, pp.1054-1062, 2012.
DOI : 10.1161/ATVBAHA.111.244616

A. Woywodt, A. Blann, T. Kirsch, U. Erdbruegger, N. Banzet et al., Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol, Journal of Thrombosis and Haemostasis, vol.2, issue.3, pp.671-678, 2006.
DOI : 10.1002/ajh.10101

D. Smadja, L. Mauge, P. Gaussem, C. Audigier, D. Israel-biet et al., Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension, Angiogenesis, vol.347, issue.1, pp.17-27, 2011.
DOI : 10.1056/NEJMoa020204

D. Sutherland, L. Anderson, M. Keeney, and R. Nayar, The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry, Journal of Hematotherapy, vol.5, issue.3, pp.213-239, 1996.
DOI : 10.1089/scd.1.1996.5.213

B. Granel, A. Daumas, E. Jouve, J. Harlé, P. Nguyen et al., Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial, Annals of the Rheumatic Diseases, vol.74, issue.12, pp.2175-82, 2015.
DOI : 10.1136/annrheumdis-2014-205681

P. Guillaume-jugnot, A. Daumas, J. Magalon, E. Jouve, P. Nguyen et al., Autologous adipose-derived stromal vascular fraction in patients with systemic sclerosis: 12-month follow-up, Rheumatology, vol.31, issue.2, pp.301-307, 2016.
DOI : 10.1002/art.10486
URL : https://hal.archives-ouvertes.fr/hal-01452751

N. Kavian, W. Marut, A. Servettaz, C. Nicco, C. Chéreau et al., Pantethine Prevents Murine Systemic Sclerosis Through the Inhibition of Microparticle Shedding, Arthritis & Rheumatology, vol.104, issue.7, pp.1881-90, 2015.
DOI : 10.1172/JCI4985

C. Jung, K. Drummer, P. Oelzner, H. Figulla, J. Boettcher et al., The association between endothelial microparticles and inflammation in patients with systemic sclerosis and Raynaud???s phenomenon as detected by functional imaging, Clinical Hemorheology and Microcirculation, vol.71, issue.3, pp.549-57, 2015.
DOI : 10.1136/annrheumdis-2010-148288

L. Iversen, S. Ullman, O. Østergaard, C. Nielsen, P. Halberg et al., Cross-sectional study of soluble selectins, fractions of circulating microparticles and their relationship to lung and skin involvement in systemic sclerosis, BMC Musculoskeletal Disorders, vol.103, issue.2, p.191, 2015.
DOI : 10.1160/TH09-09-0644

P. Lanuti, G. Rotta, C. Almici, G. Avvisati, A. Budillon et al., Endothelial progenitor cells, defined by the simultaneous surface expression of VEGFR2 and CD133, are not detectable in healthy peripheral and cord blood, Cytometry Part A, vol.273, issue.3, pp.259-70, 2016.
DOI : 10.1002/cyto.b.20085

W. Qin, Z. Li, S. Luo, R. Wu, Z. Pei et al., Exogenous fractalkine enhances proliferation of endothelial cells, promotes migration of endothelial progenitor cells and improves neurological deficits in a rat model of ischemic stroke, Neuroscience Letters, vol.569, pp.80-84, 2014.
DOI : 10.1016/j.neulet.2014.03.052

O. Herlea-pana, L. Yao, J. Heuser-baker, Q. Wang, Q. Wang et al., Chemokine receptors CXCR2 and CX3CR1 differentially regulate functional responses of bone-marrow endothelial progenitors during atherosclerotic plaque regression, Cardiovascular Research, vol.26, issue.5, pp.324-361, 2015.
DOI : 10.1016/j.tibtech.2008.01.005

D. Todorova, F. Sabatier, E. Doria, L. Lyonnet, H. Vacher-coponat et al., Fractalkine Expression Induces Endothelial Progenitor Cell Lysis by Natural Killer Cells, PLoS ONE, vol.6, issue.10, p.26663, 2011.
DOI : 10.1371/journal.pone.0026663.t001